首页 | 官方网站   微博 | 高级检索  
     

腰交感神经节微创介入置管连续给药在糖尿病足治疗中的应用价值
引用本文:汪业铭,高 艳,李树铁,赵继波,李媛莉.腰交感神经节微创介入置管连续给药在糖尿病足治疗中的应用价值[J].现代生物医学进展,2020(13):2541-2544.
作者姓名:汪业铭  高 艳  李树铁  赵继波  李媛莉
作者单位:河北北方学院附属第一医院疼痛科 河北 张家口 075061
基金项目:河北省医学科学研究重点课题计划项目(20170774)
摘    要:目的:探讨腰交感神经节微创介入置管连续给药在糖尿病足治疗中的应用价值。方法:选取2016年6月-2017年6月期间在我院诊治的40例糖尿病足患者。按随机数字表法分为研究组(n=20)和对照组(n=20)。对照组给予常规治疗,研究组使用腰交感神经节微创介入置管连续给药治疗。对比分析两组视觉模拟评分(VAS)、治疗总有效率、并发症发生情况。结果:两组治疗前VAS评分比较差异无统计学意义(P0.05);两组治疗后VAS评分均下降,且研究组较对照组降低(P0.05)。研究组治疗后的临床总有效率为95.00%(19/20),高于对照组的70.00%(14/20)(P0.05)。治疗后研究组踝肱指数(ABI)和皮温高于对照组,震动感觉阈值(VPT)低于对照组,差异均有统计学意义(P0.05);治疗后研究组患者溃疡愈合时间和住院时间短于对照组,两组比较差异具有统计学意义(P0.05)。两组治疗后并发症发生率比较无统计学差异(P0.05)。结论:使用腰交感神经节微创介入置管连续给药治疗糖尿病足,可显著提高治疗总有效率,减轻患者疼痛,缩短溃疡愈合时间及住院时间,减少截肢率,且安全性较好。

关 键 词:腰交感神经节微创介入  连续给药  糖尿病足  疗效
收稿时间:2019/11/23 0:00:00
修稿时间:2019/12/17 0:00:00

The Applied Value of Continuous Infusion by Lumbar Sympathetic Ganglion Minimally Invasive Interventional Catheterization in the Treatment of Diabetic Foot
WANG Ye-ming,GAO Yan,LI Shu-tie,ZHAO Ji-bo,LI Yuan-li.The Applied Value of Continuous Infusion by Lumbar Sympathetic Ganglion Minimally Invasive Interventional Catheterization in the Treatment of Diabetic Foot[J].Progress in Modern Biomedicine,2020(13):2541-2544.
Authors:WANG Ye-ming  GAO Yan  LI Shu-tie  ZHAO Ji-bo  LI Yuan-li
Affiliation:Department of Pain, The First Affiliated Hospital of Hebei North University, Zhangjiakou, Hebei, 075061, China
Abstract:ABSTRACT Objective: To Investigate the applied value of continuous infusion by lumbar sympathetic ganglion minimally invasive interventional catheterization in the treatment of diabetic foot. Methods: 40 patients with diabetic foot treated in our hospital from June 2016 to June 2017 were selected. The patients were randomly divided into study group (n=20) and control group (n=20) according to the random number method. The control group received conventional treatment, the study group applied continuous infusion by lumbar sympathetic ganglion minimally invasive interventional catheterization to treat. Visual analogue score (VAS), total effective rate, complications in the two groups were compared and analyzed. Results: There was no significant difference in VAS score between the two groups before treatment(P>0.05). VAS scores of both groups decreased after treatment, the study group was lower than the control group(P<0.05). The total clinical effective rate after treatment in the study group was 95.00% (19/20), higher than 70.00% (14/20) in the control group(P<0.05). After treatment, the ankle brachial index (ABI)and skin temperature in the study group were higher than those in the control group, and the vibration perception threshold (VPT) was lower than that in the control group, with statistical significance (P<0.05); the ulcer healing time and hospitalization time in the study group were shorter than those in the control group, with statistical significance (P<0.05). There was no difference in the incidence of postoperative complications between the two groups(P>0.05). Conclusion: Using lumbar sympathetic ganglion minimally invasive interventional catheterization for continuous treatment of diabetic foot can significantly improve the total effective rate of treatment, reduce the pain of patients, shorten the time of ulcer healing and hospitalization, reduce the rate of amputation, and have good safety.
Keywords:Lumbar sympathetic ganglion minimally invasive intervention  Continuous infusion  Diabetic foot  Curative effect
本文献已被 CNKI 等数据库收录!
点击此处可从《现代生物医学进展》浏览原始摘要信息
点击此处可从《现代生物医学进展》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号